Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Cyclic peptides
Patent
1995-06-06
2000-02-22
Celsa, Bennett
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Cyclic peptides
530302, 530307, 530311, 530315, 530328, 530329, 514 14, 514 15, 514 16, 514 17, 930 80, A61K 3812, C07K 700
Patent
active
060281685
ABSTRACT:
Disclosed are lanthionine peptides having the structure ##STR1## methods of their preparation and use as pharmacologically active agents.
REFERENCES:
patent: 3446789 (1969-05-01), Rudinger et al.
patent: 3980631 (1976-09-01), Prochazka et al.
patent: 4349544 (1982-09-01), Cort et al.
patent: 4482486 (1984-11-01), Brtnik et al.
Degrado, Design of Peptides avd Proteins, Advances in Protein Chemistry, vol. 39, pp. 51-62, 1988.
Hruby, Minireview, Conformational Restrictions of Biologically Active Peptides via Amino Acid Side Chain Groups, Life Sciences, vol. 31 pp. 189-199, 1982.
Goodman Murray
Osapay George
Celsa Bennett
Winfried Kolbeck
LandOfFree
Lanthionine bridged peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lanthionine bridged peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lanthionine bridged peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-521419